CAROL G HOLLADAY & ASSOCIATES

Lobbying for PHARMADVA · manufacturing & distribution medical device contracted through prosthetics in VA Med Ctrs

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jul 20, 2026.

Filing Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$8,000.00

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Bills named in this filing 2

HR 2148
Veteran Caregiver Reeducation, Reemployment, and Retirement Act
S 1874
Title VIII Nursing Workforce Reauthorization Act of 2026

Lobbying activity 1

Veterans

Congressional Meetings to introduce PharmAdva's Medacube to Members of Congress and their staffs. Buy American issues and tariff increases in China. Medacube has 2 small components made in China and is trying to move manufacturing those components to US. HR 2148 - Veteran Caregiver Reeducation, Reemployment, and Retirement Act, meeting to support with Cong. Bergman (MI). S. 1874 -Title VIII Nursing Workforce Reauthorization Act of 2025 reauthorizes through FY2026 and revises various programs and activities of the Centers for Medicare & Medicaid Services - communicated support with NY, WY, FL, and TN Delegations. VA Meetings with VISNs Home-Based Primary Care Departments, Meetings with NY Delegation to support research base in Rochester and relocating manufacturing of some components to US. Meeting with Congresswoman Tenney staff to discuss SBIR funding and support of NIA grant application.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.